Efficacy of the hypoxia-activated prodrug evofosfamide (TH-302) in nasopharyngeal carcinoma in vitro and in vivo

BACKGROUND: Tumor hypoxia is considered an important factor in metastasis and disease relapse. Evofosfamide is a hypoxia-activated prodrug that selectively targets the hypoxic regions of solid tumors. As hypoxia-inducible factor-1α (HIF-1α) is overexpressed in nasopharyngeal carcinoma (NPC) tissues,...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Yan, Tian, Ying, Zhao, Yuanyuan, Xue, Cong, Zhan, Jianhua, Liu, Lin, He, Xiaobo, Zhang, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5993153/
https://www.ncbi.nlm.nih.gov/pubmed/29764490
http://dx.doi.org/10.1186/s40880-018-0285-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5993153/
https://www.ncbi.nlm.nih.gov/pubmed/29764490
http://dx.doi.org/10.1186/s40880-018-0285-0

Ejemplares similares